Chestrub

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the temporary relief of symptoms associated with the common cold, including cough, nasal congestion, and chest congestion. Additionally, it provides temporary relief from minor aches and pains of muscles.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the chest and throat. If desired, the area may be loosely covered with a soft cloth; however, it is important to ensure that clothing remains loose to avoid any restriction.

This application may be repeated up to three times daily, or as directed by a healthcare professional.

For children under 2 years of age, it is recommended to consult a doctor before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application near an open flame due to fire hazard.

• Addition of water, as this may compromise product integrity.

• Oral ingestion, which is not intended for this product.

• Use in a microwave oven, as it may lead to unsafe heating.

• Application on wounds or damaged skin, which may exacerbate injury or cause irritation.

• Use with tight bandages, as this may restrict circulation or cause skin irritation.

• Application in nostrils, which is not recommended.

• Addition to hot water or any container intended for heating, as this may cause splattering and result in burns.

Warnings and Precautions

For external use only; contact with eyes should be strictly avoided to prevent irritation or injury.

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately to ensure appropriate management.

Healthcare professionals should advise patients to discontinue use and consult a physician if muscle aches and pains persist for more than 7 days, recur, or are accompanied by fever, rash, or a headache that lasts. These symptoms may indicate a serious underlying condition that requires further evaluation. Additionally, it is essential for pregnant or breastfeeding individuals to consult a physician prior to use to assess potential risks to the mother and child.

Side Effects

Patients using this product should be aware that it is for external use only and must avoid contact with the eyes.

In clinical practice, patients are advised to stop use and consult a doctor if muscle aches and pains persist for more than 7 days, recur, or occur alongside fever, rash, or a headache that lasts. These symptoms may indicate a serious underlying condition.

Additionally, patients should seek medical advice before using this product if they have a chronic cough that lasts or occurs in conjunction with smoking, asthma, or emphysema, or if they experience a cough accompanied by excessive phlegm (mucus).

It is also recommended that pregnant or breastfeeding individuals consult a physician prior to use to ensure safety for both the mother and child.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Chestrub (camphor menthol eucalyptus oil). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat. If desired, a soft cloth may be loosely placed over the area, ensuring that clothing remains loose. This application may be repeated up to three times daily or as directed by a healthcare provider.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a physician before using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a physician prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare professionals should consider the potential risks and benefits when recommending this medication to lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and interventions tailored to the situation.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Patients should be informed to discontinue use and consult a physician if muscle aches and pains persist for more than 7 days, recur, or are accompanied by fever, rash, or a headache that lasts. These symptoms may indicate a serious underlying condition that requires medical evaluation.

For patients who are pregnant or breastfeeding, it is essential to recommend consulting a physician prior to using the product to ensure safety for both the patient and the child.

Healthcare providers should also encourage patients to speak with a doctor before using the product if they have a chronic cough that lasts or occurs in conjunction with smoking, asthma, or emphysema. Additionally, patients with a cough that produces excessive phlegm (mucus) should be advised to consult a physician before use to rule out any serious health issues.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to prevent contamination and degradation. Additionally, the product should be protected from light exposure to ensure optimal stability. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

Patients aged 2 years and older are instructed to apply a thick layer of the product to the chest and throat, with the option to loosely cover the area with a soft cloth while ensuring clothing remains loose. This application may be repeated up to three times daily or as directed by a physician.

Clinicians should advise patients who are pregnant or breastfeeding to consult a physician prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Chestrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)